Sandostatin 500 mcg/mL injection Images
Generic Name: octreotide
This medication has been identified as Sandostatin 500 mcg/mL injection. It is supplied by Novartis Pharmaceuticals Corporation.
Sandostatin is used in the treatment of Carcinoid Tumor; Acromegaly; Vasoactive Intestinal Peptide Tumor and belongs to the drug class somatostatin and somatostatin analogs. There is no proven risk in humans during pregnancy. Sandostatin 500 mcg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Sandostatin
- Generic Name
- octreotide
- Strength
- 500 mcg/mL injection
- Availability
- Prescription only
- Drug Class
- Somatostatin and somatostatin analogs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0182
More about Sandostatin (octreotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.